[1]
R. T. Firmansyah and L. N. Amalia, “The Analysis Study of Effects of Glucagon-Like Peptide-1 Receptor to Reduce Adverse Cardiovascular Events in Patients with Type 2 Diabetes Mellitus: A Comprehensive Systematic Review”, the int. j. of med. science and health, vol. 4, no. 2, pp. 1–19, Sep. 2024, doi: 10.70070/1qe6dr94.